Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Schedule of number of cash-settled RSUs granted

​

​

​

​

​

​

​

​

Nine months ended

​

​

​

​

September 30, 2024

​

​

​

​

RSUs Granted (000's)

​

​

​

​

​

​

​

QRTEA time-based RSUs, subsidiary employees (1)

​

21,171

​

​

QRTEA performance-based RSUs, subsidiary employees (2)

​

20,409

​

​

QRTEA performance-based RSUs, Qurate Retail employees (3)

​

941

​

​

(1) Grants mainly vest equally over three years.
(2) Grants mainly vest equally over three years, subject to the satisfaction of certain performance objectives.
(3) Grants mainly vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

Series A

​

Average

​

Series B

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

RSUs outstanding at January 1, 2024

 

14,691

​

$

3.30

​

353

​

$

5.51

​

Granted

 

3,741

​

$

1.23

​

296

​

$

5.01

​

Vested

 

(5,702)

​

$

3.74

​

(353)

​

$

4.85

​

Forfeited/Cancelled

 

(2,253)

​

$

2.34

​

—

​

$

—

​

RSUs outstanding at September 30, 2024

 

10,477

​

$

2.52

​

296

​

$

5.01

 

Common stock Series A  
Share-Based Payment Arrangement, Activity [Table Text Block]

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series A

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

23,530

​

$

7.72

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

 

(3,580)

​

$

10.24

​

​

​

​

​

​

​

Options outstanding at September 30, 2024

 

19,950

​

$

7.27

 

2.0

years

​

$

—

​

Options exercisable at September 30, 2024

 

17,755

​

$

7.11

 

1.9

years

​

$

—

​

Common stock Series B  
Share-Based Payment Arrangement, Activity [Table Text Block]

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series B

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

723

​

$

12.35

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

​

(316)

​

$

11.59

​

​

​

​

​

​

​

Options outstanding at September 30, 2024

 

407

​

$

12.95

 

0.5

years

​

$

—

​

Options exercisable at September 30, 2024

 

407

​

$

12.95

 

0.5

years

​

$

—

​

​

​